Definition of a solvent system for spherical crystallization of salbutamolsulfate by quasi-emulsion solvent diffusion (QESD) method

Citation
M. Nocent et al., Definition of a solvent system for spherical crystallization of salbutamolsulfate by quasi-emulsion solvent diffusion (QESD) method, J PHARM SCI, 90(10), 2001, pp. 1620-1627
Citations number
14
Categorie Soggetti
Pharmacology & Toxicology
Journal title
JOURNAL OF PHARMACEUTICAL SCIENCES
ISSN journal
00223549 → ACNP
Volume
90
Issue
10
Year of publication
2001
Pages
1620 - 1627
Database
ISI
SICI code
0022-3549(200110)90:10<1620:DOASSF>2.0.ZU;2-F
Abstract
In this paper we describe how the spherical crystallization process by QESD method can be applied to a water-soluble drug, salbutamol sulfate. The typ e of solvent, antisolvent, and emulsifier and the concentration of emulsifi er to be used for the production of spherical particles with a size range 8 0-500 mum are determined. Furthermore, the solvent/antisolvent ratio and th e temperature difference between them (DeltaT) are studied. It was observed that, in the case of salbutamol sulfate, the DeltaT value has no influence on the formation of spherical particles. A very large metastable zone of s albutamol sulfate in water could explain this phenomenon. Finally, the infl uence of emulsifier concentration and of maturation time on the size of sph erical particles is studied. The results show that these two parameters mus t be fixed to control the size of the recovered particles. (C) 2001 Wiley-L iss, Inc. and the American Pharmaceutical Association.